Search Within

Joachim Yahalom

  1. "2023"
Formats
  1. Meeting Abstract (40)
  2. Journal Article (6)
  3. Research Letter (1)
  4. Review (1)
Groups
  1. Radiation Oncology, Department of (48)
  2. Survivorship Research (48)
  3. Graduate Medical Education (37)
  4. Department of Medicine (33)
  5. Hematologic Malignancies, Division of (33)
  6. GME, Radiation Oncology (31)

More Groups

People
  1. Brandon Imber (39)
  2. Carla Hajj (27)
  3. Beatrice Fregonese (23)
  4. Gilles Salles (21)
  5. Kathryn Tringale (20)
  6. Harper Hubbeling (16)

More People

Years
  1. 2023 (48)
Publications
  1. Hematological Oncology (20)
  2. Blood (12)
  3. International Journal of Radiation Oncology, Biology, Physics (5)
  4. Radiotherapy and Oncology (3)
  5. Blood Advances (2)
  6. British Journal of Haematology (1)

More Publications

Publishers
  1. Wiley Blackwell (20)
  2. American Society of Hematology (14)
  3. Elsevier Inc. (9)
  4. John Wiley & Sons (1)
  5. MDPI (1)
  6. Nature Publishing Group (1)

More Publishers

Results (48)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2 trial of nivolumab plus adriamycin, vinblastine, dacarbazine (N‐AVD) as frontline therapy in older adults with Hodgkin lymphoma
    Meeting Abstract

    Torka, P.; Feldman, T.; Savage, K.; Ganesan, N.; Hancock, H.; Davey, T.; Perez, L.; Santarosa, A.; Subzwari, S.; Capadona, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T‐cell therapy outcome
    Meeting Abstract

    Imber, B. S.; Silverman, E. A.; Leithner, D.; Hubbeling, H.; Shah, G. L.; Fregonese, B.; Sanin, B. W.; Tomas, A. A.; Parascondola, A.; Saldia, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Predictors of survival in patients with MALT lymphoma: A retrospective, case-control study
    Review

    Qi, S.; Liu, X.; Noy, A.; Lee, J.; Teckie, S.; Hajj, C.; Joffe, E.; Imber, B. S.; Yahalom, J.
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Outcomes of patients with positive interim positron emission tomography (PET) continuing ABVD in the clinical setting
    Journal Article

    Zheng, S.; Gupta, K.; Goyal, P.; Nakajima, R.; Michaud, L.; Batlevi, C. L.; Hamlin, P. A.; Horwitz, S.; Kumar, A.; Matasar, M. J.; more...
    Cancers (2023)

    Fulltext@MSK | Save
  • Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma
    Journal Article

    Alarcon Tomas, A.; Fein, J. A.; Fried, S.; Flynn, J. R.; Devlin, S. M.; Fingrut, W. B.; Anagnostou, T.; Alperovich, A.; Shah, N.; Fraint, E.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Long-term outcomes of patients with limited-stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era
    Research Letter

    Qualls, D.; Imber, B. S.; Okwali, M.; Hamlin, P. A.; Kumar, A.; Lahoud, O. B.; Matasar, M. J.; Noy, A.; Owens, C.; Zelenetz, A. D.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Assessment of lymphoma and other hematologic malignancies training needs among radiation oncology residents: A brief report
    Journal Article

    Kahn, J. M.; Yang, J. C.; Yahalom, J.; Dabaja, B. S.; Vapiwala, N.; Hoppe, B. S.; Tseng, Y. D.; Pinnix, C. C.; Parikh, R. R.; Sim, A. J.; more...
    Journal of Cancer Education (2023)

    Fulltext@MSK | Save